Brief: Infant Bacterial Therapeutics Q3 operating loss narrows to SEK 4.6 mln
Nov 23 (Reuters) - INFANT BACTERIAL THERAPEUTICS AB
IBTb.ST
* Q3 OPERATING LOSS SEK 4.6 MILLION VERSUS LOSS SEK 7.9
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE827JRt
Further company coverage: IBTb.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln